Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis-Reference-Cited by-同舟云学术

Novel recombinant BCG expressing perfringolysin O and the over-expression of key immunodominant antigens; pre-clinical characterization, safety and protection against challenge with Mycobacterium tuberculosis

Published:2009-07 Issue:33 Volume:27 Page:4412-4423
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Sun Ronggai,Skeiky Yasir A.W.,Izzo Angelo,Dheenadhayalan Veerabadran,Imam Zakaria,Penn Erica,Stagliano Katherine,Haddock Scott,Mueller Stefanie,Fulkerson John,Scanga Charles,Grover Ajay,Derrick Steven C.,Morris Sheldon,Hone David M.,Horwitz Marcus A.,Kaufmann Stefan H.E.,Sadoff Jerald C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference74 articles.

1. In vitro cellular immune responses to complex and newly defined recombinant antigens of Mycobacterium tuberculosis;Al-Attiyah;Clin Exp Immunol,2004

2. Coordinate cytokine gene expression in vivo following induction of tuberculous pleurisy in guinea pigs;Allen;Infect Immun,2003

3. Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins;Andersen;Infect Immun,1994

4. The success and failure of BCG—implications for a novel tuberculosis vaccine;Andersen;Nat Rev Microbiol,2005

5. Tuberculosis: a global emergency;Anon.;World Health Forum,1993

Cited by 133 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen identification strategies and preclinical evaluation models for advancing tuberculosis vaccine development;npj Vaccines;2024-03-09

2. Mycobacterium tuberculosis Central Metabolism Is Key Regulator of Macrophage Pyroptosis and Host Immunity;Pathogens;2023-08-30

3. Vaccines against Tuberculosis: Where Are We Now?;Vaccines;2023-05-22

4. Fighting Tuberculosis: In Search of a BCG Replacement;Microorganisms;2022-12-23

5. Recent Developments in Mycobacteria-Based Live Attenuated Vaccine Candidates for Tuberculosis;Biomedicines;2022-10-29